Increase bone mineral density

Increase bone mineral density with Preotact®

Osteoporosis reduces bone mineral density and increases the risk of bone fracture. Reduction of bone mineral density is often related to estrogen deficiency following menopause. Men can also experience reduced bone mineral density due to a decrease in testosterone levels.

Preotact® offers treatment for osteoporosis by increasing bone mineral density. Preotact® is a full-length parathyroid hormone (PTH) therapy for postmenopausal osteoporosis patients to reduce the risk of bone fracture. Studies have demonstrated that Preotact® can increase bone mineral density in the spine and hip.

Log in to learn more about how to increase bone mineral density

Nycomed

Nycomed is a European pharmaceutical company that has over 20 years’ experience of working with osteoporosis. Nycomed operates throughout Europe and in fast-growing markets in Latin America, Russia/CIS and Asia-Pacific.

Nycomed provides medicines and products for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets. Offering a broad portfolio of products in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management.